News
What to know about the new mRNA flu vaccine
The FDA has approved an mRNA vaccine for seasonal influenza, offering a new approach to preventing a virus that causes widespread illness each year. The technol
By Johns Hopkins News Staff · 2026-09-09T09:05:52.482Z
The FDA has approved an mRNA vaccine for seasonal influenza, offering a new approach to preventing a virus that causes widespread illness each year. The technology could speed vaccine development and improve responses to changing strains, but its effectiveness, safety, availability and cost remain key questions. The article examines what the approval means for future flu prevention.
Read the full article here https://hub.jhu.edu/2026/09/08/new mrna flu vaccine/